AnalystsDennis DingDennis Ding's Stock Forecasts
AnalystsDennis Ding
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4504 out of 4870 analysts
Average Return
-36.96%
Win Rate
15%2 out of 13
Risk vs Reward
Poor
Good
Dennis Ding's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cincor Pharma IncCINC | +52.26% | $19.00 | $28.93 | 2022-01-31 - 2023-01-31 | Strong Buy |
Arbutus Biopharma CorpABUS | +0.35% | $2.89 | $2.90 | 2022-02-01 - 2023-02-01 | Strong Buy |
Dennis Ding Analyst Color
Get additional color on Dennis Ding's coverage of popular stocks
Dennis Ding's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $55.00 | +64.08% | Upgrades | 3 months ago |
Inhibikase Therapeutics IncIKT | 1 | Strong Buy | $8.00 | +257.14% | Initiates Coverage On | 6 months ago |
Assembly Biosciences IncASMB | 1 | Strong Buy | $35.00 | +205.94% | Upgrades | 7 months ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $18.00 | +169.46% | Initiates Coverage On | 8 months ago |
Arbutus Biopharma CorpABUS | 2 | Strong Buy | $7.00 | +93.91% | Maintains | 8 months ago |
Recursion Pharmaceuticals IncRXRX | 1 | Hold | $6.00 | +9.09% | Maintains | 8 months ago |
Lyra Therapeutics IncLYRA | 1 | Hold | $0.50 | +346.43% | Downgrades | a year ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $216.00 | N/A | Reiterates | 2 years ago |
Corcept Therapeutics IncCORT | 1 | Hold | $22.00 | N/A | Downgrades | 2 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cincor Pharma IncCINC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Pardes Biosciences IncPRDS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Sigilon Therapeutics IncSGTX | 2 | Hold | $52.00 | N/A | Downgrades | 3 years ago |
Roivant Sciences LtdROIV | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.